Literature DB >> 14653684

Palladium-catalyzed sequential alkylation-alkenylation reactions: new three-component coupling leading to oxacycles.

Sandrine Pache1, Mark Lautens.   

Abstract

A new three-component domino reaction catalyzed by palladium was devised, producing polysubstituted bicyclic molecules in good yields from readily available substrates. The reaction conditions and the scope of the process were examined, and a possible mechanism is proposed. [reaction: see text]

Entities:  

Year:  2003        PMID： 14653684     DOI： 10.1021/ol035806t

Source DB:  PubMed          Journal:  Org Lett        ISSN： 1523-7052            Impact factor:   6.005


  5 in total

1.  Diastereoselective synthesis of fused [1,3]oxazines from ethyl pyruvate, activated acetylenes and N-heterocycles.

Authors:  Issa Yavari; Anvar Mirzaei; Zinatosadat Hossaini; Sanaz Souri
Journal:  Mol Divers       Date:  2009-07-04       Impact factor: 2.943

2.  Palladium/Norbornene Cooperative Catalysis.

Authors:  Jianchun Wang; Guangbin Dong
Journal:  Chem Rev       Date:  2019-04-25       Impact factor: 60.622

3.  Entry to 1,2,3,4-Tetrasubstituted Arenes through Addressing the "Meta Constraint" in the Palladium/Norbornene Catalysis.

Authors:  Jianchun Wang; Yun Zhou; Xiaolong Xu; Peng Liu; Guangbin Dong
Journal:  J Am Chem Soc       Date:  2020-01-30       Impact factor: 15.419

4.  Visible Light-Promoted Green and Sustainable Approach for One-Pot Synthesis of 4,4'-(Arylmethylene)bis(1H-pyrazol-5-ols), In Vitro Anticancer Activity, and Molecular Docking with Covid-19 Mpro.

Authors:  Anamika Gupta; Safia Iqbal; Mohd Kamil Hussain; Mohd Rehan Zaheer; Krapa Shankar
Journal:  ACS Omega       Date:  2022-09-14

5.  5'-([1,1'-Biphen-yl]-4-yl)-1',1'',3''-tri-methyl-dispiro[indane-2,2'-pyrrolidine-4',5''-[1,3]diazin-ane]-1,3,2'',4'',6''-penta-one.

Authors:  Hosamani Amar; Yellappa Shivaraj; Giriyapura R Vijayakumar; Bandrehalli Siddagangaiah Palakshamurthy
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2014-06-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.